Mobia Medical financials
$9.02+2.15%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 |
|---|---|
| Revenue | $13.5M |
| Gross profit | $11.2M |
| Gross margin | 83.2% |
| Operating income | -$17.9M |
| Net income | -$21.0M |
| Net margin | −155.8% |
| Diluted EPS | $-1.10 |
| EBITDA | -$17.8M |
| Operating cash flow | -$15.7M |
| Free cash flow | -$17.2M |
| Diluted shares | 19.1M |
Balance sheet
| Period end | Jun 30 |
|---|---|
| Cash & equivalents | $177.1M |
| Short-term investments | $0.00 |
| Total debt | $7.3M |
| Total assets | $195.3M |
| Total liabilities | $22.7M |
| Shareholders' equity | $172.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology